AGÕæÈ˹ٷ½

STOCK TITAN

[8-K] Aveanna Healthcare Holdings Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Aspen Aerogels, Inc. (NYSE: ASPN) filed a Form 8-K on 7 Aug 2025.

  • Item 2.02: Furnishes a press release (Exhibit 99.1) announcing Q2-25 results for the period ended 30 Jun 2025.
  • Item 7.01: Simultaneously furnishes forward-looking commentary covering the company’s second-half 2025 outlook and a planned CFO transition to an internal successor.
  • Because the information is “furnishedâ€� rather than “filed,â€� it is not subject to Section 18 liability and is excluded from incorporation by reference unless specifically stated.
  • The body of the 8-K contains no quantitative financial data; investors must consult Exhibit 99.1 for revenue, EPS, margin and guidance figures.
  • Ricardo C. Rodriguez, current CFO & Treasurer, signed the filing, indicating leadership continuity during the transition.

No share issuances, debt agreements or other material transactions are disclosed. The filing is primarily procedural, aimed at maintaining Reg FD compliance and timely investor communication.

Aspen Aerogels, Inc. (NYSE: ASPN) ha presentato un Modulo 8-K il 7 agosto 2025.

  • Voce 2.02: Fornisce un comunicato stampa (Allegato 99.1) che annuncia i risultati del secondo trimestre 2025 per il periodo terminato il 30 giugno 2025.
  • Voce 7.01: Contemporaneamente fornisce commenti previsionali riguardanti le prospettive della seconda metà del 2025 e una pianificata transizione del CFO a un successore interno.
  • Poiché le informazioni sono "fornite" e non "depositate", non sono soggette alla responsabilità ai sensi della Sezione 18 e sono escluse dall'incorporazione per riferimento salvo diversa indicazione.
  • Il corpo del modulo 8-K non contiene dati finanziari quantitativi; gli investitori devono consultare l'Allegato 99.1 per ricavi, EPS, margini e dati previsionali.
  • Ricardo C. Rodriguez, attuale CFO e Tesoriere, ha firmato il documento, indicando continuità nella leadership durante la transizione.

Non sono state comunicate emissioni di azioni, accordi di debito o altre transazioni rilevanti. Il deposito è principalmente di natura procedurale, volto a mantenere la conformità al Reg FD e garantire una comunicazione tempestiva agli investitori.

Aspen Aerogels, Inc. (NYSE: ASPN) presentó un Formulario 8-K el 7 de agosto de 2025.

  • Artículo 2.02: Proporciona un comunicado de prensa (Exhibición 99.1) que anuncia los resultados del segundo trimestre de 2025 para el periodo finalizado el 30 de junio de 2025.
  • Artículo 7.01: Simultáneamente ofrece comentarios prospectivos sobre las perspectivas para la segunda mitad de 2025 y una transición planificada del CFO a un sucesor interno.
  • Debido a que la información es "proporcionada" y no "presentada", no está sujeta a responsabilidad según la Sección 18 y queda excluida de la incorporación por referencia a menos que se indique explícitamente.
  • El cuerpo del 8-K no contiene datos financieros cuantitativos; los inversionistas deben consultar la Exhibición 99.1 para cifras de ingresos, EPS, márgenes y proyecciones.
  • Ricardo C. Rodriguez, actual CFO y Tesorero, firmó la presentación, indicando continuidad en el liderazgo durante la transición.

No se divulgan emisiones de acciones, acuerdos de deuda ni otras transacciones materiales. La presentación es principalmente procedimental, destinada a mantener el cumplimiento del Reg FD y asegurar una comunicación oportuna con los inversionistas.

Aspen Aerogels, Inc. (NYSE: ASPN)ëŠ� 2025ë…� 8ì›� 7ì� Form 8-Kë¥� 제출했습니다.

  • 항목 2.02: 2025ë…� 6ì›� 30ì� 종료ë� 기간ì� 2분기 실ì ì� 발표하는 ë³´ë„ìžë£Œ(첨부문서 99.1)ë¥� 제공합니ë‹�.
  • 항목 7.01: ë™ì‹œì—� 2025ë…� 하반ê¸� ì „ë§ê³� ë‚´ë¶€ 후임ìžì—ê²� CFO 전환 계íšì—� 대í•� ë¯¸ëž˜ì§€í–¥ì  ì½”ë©˜í„°ë¦¬ë¥� 제공합니ë‹�.
  • ì •ë³´ê°€ "제출"ì� 아닌 "제공"ë� 것ì´ë¯€ë¡� 섹션 18 ì±…ìž„ 대ìƒì´ 아니ë©�, 명시ì ìœ¼ë¡� 언급ë˜ì§€ 않는 í•� 참조 통합ì—서 제외ë©ë‹ˆë‹�.
  • 8-K 본문ì—는 정량ì � 재무 ë°ì´í„°ê°€ í¬í•¨ë˜ì–´ 있지 않으ë©�, 투ìžìžëŠ” 매출, 주당순ì´ì�, 마진 ë°� ê°€ì´ë˜ìŠ� 수치ë¥� 확ì¸í•˜ë ¤ë©� 첨부문서 99.1ì� 참조해야 합니ë‹�.
  • 현재 CFO ê²� 재무담당ìžì¸ Ricardo C. Rodriguezê°€ 서명하여 전환 기간 ë™ì•ˆ 리ë”ì‹­ì˜ ì—°ì†ì„±ì„ 나타냅니ë‹�.

ì£¼ì‹ ë°œí–‰, ë¶€ì±� 계약 ë˜ëŠ” 기타 중요í•� 거래ëŠ� 공개ë˜ì§€ 않았으며, ì� ì œì¶œì€ ì£¼ë¡œ Reg FD 준ìˆ� ë°� 투ìžìžì™€ì� ì ì‹œ 소통ì� 유지하기 위한 절차ì � 성격입니ë‹�.

Aspen Aerogels, Inc. (NYSE : ASPN) a déposé un formulaire 8-K le 7 août 2025.

  • Point 2.02 : Fournit un communiqué de presse (Exhibit 99.1) annonçant les résultats du deuxième trimestre 2025 pour la période close au 30 juin 2025.
  • Point 7.01 : Fournit simultanément des commentaires prospectifs concernant les perspectives pour le second semestre 2025 et une transition prévue du CFO vers un successeur interne.
  • Étant donné que les informations sont « fournies » et non « déposées », elles ne sont pas soumises à la responsabilité en vertu de la Section 18 et sont exclues de l’incorporation par référence sauf indication contraire.
  • Le corps du 8-K ne contient aucune donnée financière quantitative ; les investisseurs doivent consulter l’Exhibit 99.1 pour les chiffres de revenus, BPA, marges et prévisions.
  • Ricardo C. Rodriguez, CFO et trésorier actuel, a signé le dépôt, indiquant une continuité dans la direction pendant la transition.

Aucune émission d’actions, accord de dette ou autre transaction importante n’est divulguée. Le dépôt est principalement procédural, visant à maintenir la conformité au Reg FD et une communication rapide avec les investisseurs.

Aspen Aerogels, Inc. (NYSE: ASPN) reichte am 7. August 2025 ein Formular 8-K ein.

  • Posten 2.02: Stellt eine Pressemitteilung (Anlage 99.1) bereit, die die Ergebnisse für das zweite Quartal 2025 für den zum 30. Juni 2025 endenden Zeitraum ankündigt.
  • Posten 7.01: Liefert gleichzeitig zukunftsgerichtete Kommentare zur Prognose des Unternehmens für die zweite Hälfte 2025 und einen geplanten CFO-Übergang zu einem internen Nachfolger.
  • Da die Informationen "bereitgestellt" und nicht "eingereicht" wurden, unterliegen sie nicht der Haftung nach Abschnitt 18 und sind von der Einbeziehung durch Verweis ausgeschlossen, sofern nicht ausdrücklich angegeben.
  • Der Text des 8-K enthält keine quantitativen Finanzdaten; Anleger müssen Anlage 99.1 für Umsatz-, EPS-, Margen- und Prognosezahlen konsultieren.
  • Ricardo C. Rodriguez, derzeit CFO und Schatzmeister, unterzeichnete die Einreichung, was auf Kontinuität in der Führung während des Übergangs hinweist.

Es werden keine Aktienausgaben, Schuldenvereinbarungen oder andere wesentliche Transaktionen offengelegt. Die Einreichung ist hauptsächlich prozedural und dient der Einhaltung von Reg FD sowie der zeitnahen Kommunikation mit Investoren.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Procedural 8-K; impact neutral until Exhibit 99.1 details reviewed.

The company met its Reg FD obligations by promptly furnishing the press release. Without the embedded numbers, investors cannot gauge revenue growth, margins or cash burn. The mention of a CFO transition may raise short-term governance questions, but continuity is implied since the successor is internal. Overall, market impact hinges on the actual Q2 metrics and updated guidance contained in the exhibit.

TL;DR: Internal CFO succession suggests orderly hand-off; limited disclosure keeps impact muted.

Leadership changes at the CFO level can be material, yet an internal successor typically mitigates disruption. The filing confirms that Rodriguez remains CFO at signing, indicating transition planning is underway but not immediate. No changes to board composition or compensation structures are noted. From a governance lens, transparency is adequate, but investors will require successor credentials once released.

Aspen Aerogels, Inc. (NYSE: ASPN) ha presentato un Modulo 8-K il 7 agosto 2025.

  • Voce 2.02: Fornisce un comunicato stampa (Allegato 99.1) che annuncia i risultati del secondo trimestre 2025 per il periodo terminato il 30 giugno 2025.
  • Voce 7.01: Contemporaneamente fornisce commenti previsionali riguardanti le prospettive della seconda metà del 2025 e una pianificata transizione del CFO a un successore interno.
  • Poiché le informazioni sono "fornite" e non "depositate", non sono soggette alla responsabilità ai sensi della Sezione 18 e sono escluse dall'incorporazione per riferimento salvo diversa indicazione.
  • Il corpo del modulo 8-K non contiene dati finanziari quantitativi; gli investitori devono consultare l'Allegato 99.1 per ricavi, EPS, margini e dati previsionali.
  • Ricardo C. Rodriguez, attuale CFO e Tesoriere, ha firmato il documento, indicando continuità nella leadership durante la transizione.

Non sono state comunicate emissioni di azioni, accordi di debito o altre transazioni rilevanti. Il deposito è principalmente di natura procedurale, volto a mantenere la conformità al Reg FD e garantire una comunicazione tempestiva agli investitori.

Aspen Aerogels, Inc. (NYSE: ASPN) presentó un Formulario 8-K el 7 de agosto de 2025.

  • Artículo 2.02: Proporciona un comunicado de prensa (Exhibición 99.1) que anuncia los resultados del segundo trimestre de 2025 para el periodo finalizado el 30 de junio de 2025.
  • Artículo 7.01: Simultáneamente ofrece comentarios prospectivos sobre las perspectivas para la segunda mitad de 2025 y una transición planificada del CFO a un sucesor interno.
  • Debido a que la información es "proporcionada" y no "presentada", no está sujeta a responsabilidad según la Sección 18 y queda excluida de la incorporación por referencia a menos que se indique explícitamente.
  • El cuerpo del 8-K no contiene datos financieros cuantitativos; los inversionistas deben consultar la Exhibición 99.1 para cifras de ingresos, EPS, márgenes y proyecciones.
  • Ricardo C. Rodriguez, actual CFO y Tesorero, firmó la presentación, indicando continuidad en el liderazgo durante la transición.

No se divulgan emisiones de acciones, acuerdos de deuda ni otras transacciones materiales. La presentación es principalmente procedimental, destinada a mantener el cumplimiento del Reg FD y asegurar una comunicación oportuna con los inversionistas.

Aspen Aerogels, Inc. (NYSE: ASPN)ëŠ� 2025ë…� 8ì›� 7ì� Form 8-Kë¥� 제출했습니다.

  • 항목 2.02: 2025ë…� 6ì›� 30ì� 종료ë� 기간ì� 2분기 실ì ì� 발표하는 ë³´ë„ìžë£Œ(첨부문서 99.1)ë¥� 제공합니ë‹�.
  • 항목 7.01: ë™ì‹œì—� 2025ë…� 하반ê¸� ì „ë§ê³� ë‚´ë¶€ 후임ìžì—ê²� CFO 전환 계íšì—� 대í•� ë¯¸ëž˜ì§€í–¥ì  ì½”ë©˜í„°ë¦¬ë¥� 제공합니ë‹�.
  • ì •ë³´ê°€ "제출"ì� 아닌 "제공"ë� 것ì´ë¯€ë¡� 섹션 18 ì±…ìž„ 대ìƒì´ 아니ë©�, 명시ì ìœ¼ë¡� 언급ë˜ì§€ 않는 í•� 참조 통합ì—서 제외ë©ë‹ˆë‹�.
  • 8-K 본문ì—는 정량ì � 재무 ë°ì´í„°ê°€ í¬í•¨ë˜ì–´ 있지 않으ë©�, 투ìžìžëŠ” 매출, 주당순ì´ì�, 마진 ë°� ê°€ì´ë˜ìŠ� 수치ë¥� 확ì¸í•˜ë ¤ë©� 첨부문서 99.1ì� 참조해야 합니ë‹�.
  • 현재 CFO ê²� 재무담당ìžì¸ Ricardo C. Rodriguezê°€ 서명하여 전환 기간 ë™ì•ˆ 리ë”ì‹­ì˜ ì—°ì†ì„±ì„ 나타냅니ë‹�.

ì£¼ì‹ ë°œí–‰, ë¶€ì±� 계약 ë˜ëŠ” 기타 중요í•� 거래ëŠ� 공개ë˜ì§€ 않았으며, ì� ì œì¶œì€ ì£¼ë¡œ Reg FD 준ìˆ� ë°� 투ìžìžì™€ì� ì ì‹œ 소통ì� 유지하기 위한 절차ì � 성격입니ë‹�.

Aspen Aerogels, Inc. (NYSE : ASPN) a déposé un formulaire 8-K le 7 août 2025.

  • Point 2.02 : Fournit un communiqué de presse (Exhibit 99.1) annonçant les résultats du deuxième trimestre 2025 pour la période close au 30 juin 2025.
  • Point 7.01 : Fournit simultanément des commentaires prospectifs concernant les perspectives pour le second semestre 2025 et une transition prévue du CFO vers un successeur interne.
  • Étant donné que les informations sont « fournies » et non « déposées », elles ne sont pas soumises à la responsabilité en vertu de la Section 18 et sont exclues de l’incorporation par référence sauf indication contraire.
  • Le corps du 8-K ne contient aucune donnée financière quantitative ; les investisseurs doivent consulter l’Exhibit 99.1 pour les chiffres de revenus, BPA, marges et prévisions.
  • Ricardo C. Rodriguez, CFO et trésorier actuel, a signé le dépôt, indiquant une continuité dans la direction pendant la transition.

Aucune émission d’actions, accord de dette ou autre transaction importante n’est divulguée. Le dépôt est principalement procédural, visant à maintenir la conformité au Reg FD et une communication rapide avec les investisseurs.

Aspen Aerogels, Inc. (NYSE: ASPN) reichte am 7. August 2025 ein Formular 8-K ein.

  • Posten 2.02: Stellt eine Pressemitteilung (Anlage 99.1) bereit, die die Ergebnisse für das zweite Quartal 2025 für den zum 30. Juni 2025 endenden Zeitraum ankündigt.
  • Posten 7.01: Liefert gleichzeitig zukunftsgerichtete Kommentare zur Prognose des Unternehmens für die zweite Hälfte 2025 und einen geplanten CFO-Übergang zu einem internen Nachfolger.
  • Da die Informationen "bereitgestellt" und nicht "eingereicht" wurden, unterliegen sie nicht der Haftung nach Abschnitt 18 und sind von der Einbeziehung durch Verweis ausgeschlossen, sofern nicht ausdrücklich angegeben.
  • Der Text des 8-K enthält keine quantitativen Finanzdaten; Anleger müssen Anlage 99.1 für Umsatz-, EPS-, Margen- und Prognosezahlen konsultieren.
  • Ricardo C. Rodriguez, derzeit CFO und Schatzmeister, unterzeichnete die Einreichung, was auf Kontinuität in der Führung während des Übergangs hinweist.

Es werden keine Aktienausgaben, Schuldenvereinbarungen oder andere wesentliche Transaktionen offengelegt. Die Einreichung ist hauptsächlich prozedural und dient der Einhaltung von Reg FD sowie der zeitnahen Kommunikation mit Investoren.

false000183233200018323322025-08-072025-08-07

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 7, 2025

img25598497_0.jpg

Aveanna Healthcare Holdings Inc.

(Exact name of Registrant as Specified in Its Charter)

Delaware

001-40362

81-4717209

(State or Other Jurisdiction

of Incorporation)

(Commission File

Number)

(IRS Employer

Identification No.)

 

 

 

 

400 Interstate North Parkway SE, Atlanta, Georgia

(Address of Principal Executive Offices)

30339

(Zip Code)

(770)-441-1580

(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $0.01 per share

 

AVAH

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 


 

 

 


 

Item 2.02 Results of Operations and Financial Condition.

 

On August 7, 2025, Aveanna Healthcare Holdings Inc., a Delaware corporation (“we,” “us,” “our” or the “Company”), issued a press release announcing its financial results for the three and six-month periods ended June 28, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference in this Item 2.02.

 

Item 7.01 Regulation FD Disclosure.

 

The information contained in Item 2.02 of this Current Report on Form 8-K is incorporated by reference in this Item 7.01.

 

The information contained in this Current Report on Form 8-K, including in Exhibit 99.1 attached hereto, is “furnished” and not “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference in another filing under the Exchange Act or the Securities Act of 1933, as amended, except to the extent such other filing specifically incorporates such information by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit

Number

Description

99.1

Press Release dated August 7, 2025 announcing the Company’s financial results for the three and six-month periods ended June 28, 2025

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

AVEANNA HEALTHCARE HOLDINGS INC.

Date: August 7, 2025

By:

/s/ Deborah Stewart

Deborah Stewart

Chief Accounting Officer

(Principal Accounting Officer)

 

 


FAQ

What did Aspen Aerogels (ASPN) announce in its 8-K dated August 7 2025?

The company furnished a press release with Q2-25 results, a second-half outlook, and the announcement of a transition to a new internal CFO.

Does the 8-K include Aspen Aerogels� Q2 2025 revenue or EPS figures?

No. The filing references those metrics but does not disclose them; they are contained in Exhibit 99.1.

Is the disclosed information considered "filed" or "furnished"?

It is furnished, not filed, meaning it is not subject to Section 18 liabilities unless later incorporated by reference.

Why might the CFO transition matter to ASPN investors?

CFO changes can affect financial strategy and reporting quality; an internal successor typically lowers execution risk compared with an external hire.

Where can investors locate the full second-half 2025 outlook for Aspen Aerogels?

The outlook is in the press release attached as Exhibit 99.1 to the 8-K.
Aveanna Healthcare Holdings, Inc.

NASDAQ:AVAH

AVAH Rankings

AVAH Latest News

AVAH Latest SEC Filings

AVAH Stock Data

779.73M
48.73M
5.75%
88.27%
1.06%
Medical Care Facilities
Services-home Health Care Services
United States
ATLANTA